SD Biosensor, Inc. (KRX:137310)
South Korea
· Delayed Price · Currency is KRW 8,370.00
-130.00 (-1.53%)
Last updated: Apr 29, 2026, 2:01 PM KST
SD Biosensor Market Cap
SD Biosensor has a market cap or net worth of 1.01 trillion as of April 28, 2026. Its market cap has decreased by -4.79% in one year.
Market Cap
1.01T
Enterprise Value
914.31B
Revenue
710.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,370.00
Market Cap Chart
Since July 16, 2021, SD Biosensor's market cap has decreased from 6.30T to 1.01T, a decrease of -83.99%. That is a compound annual growth rate of -31.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1,005.89B | -5.52% |
| Dec 30, 2025 | 1,064.61B | -15.35% |
| Dec 30, 2024 | 1,257.73B | -10.14% |
| Dec 28, 2023 | 1,399.66B | -54.48% |
| Dec 29, 2022 | 3,074.93B | -46.40% |
| Dec 30, 2021 | 5,736.54B | -8.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.39T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 14.13T |
| Chong Kun Dang Pharmaceutical | 1,162.13B |
| Seegene | 1,143.64B |
| DongKook Pharmaceutical | 1,123.26B |
| MEDIPOST | 1,059.22B |